# Anti-cancer DC Cell Vaccination to Treat Solid Tumors

> **NCT06477614** · PHASE1 · RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Solid Tumor, Adult
- DC

## Interventions

- **BIOLOGICAL:** DC cell Vaccine

## Key facts

- **NCT ID:** NCT06477614
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-05
- **Primary completion:** 2030-12-30
- **Final completion:** 2035-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06477614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06477614, "Anti-cancer DC Cell Vaccination to Treat Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06477614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*